Ken Fisher
SCLN

Ken Fisher’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Ken Fisher’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-226,335
Closed -$2.49M – 825
2017
Q2 		$2.49M Buy
226,335
+70,712
+45% +$707K ﹤0.01% 459
2017
Q1 		$1.52M Buy
155,623
+39,406
+34% +$394K ﹤0.01% 480
2016
Q4 		$1.25M Sell
116,217
-106,610
-48% -$1.07M ﹤0.01% 485
2016
Q3 		$2.28M Sell
222,827
-75,187
-25% -$819K ﹤0.01% 448
2016
Q2 		$3.99M Sell
298,014
-161,593
-35% -$2.12M 0.01% 374
2016
Q1 		$5.86M Sell
459,607
-25,241
-5% -$224K 0.01% 335
2015
Q4 		$4.46M Buy
484,848
+86,422
+22% +$723K 0.01% 357
2015
Q3 		$2.77M Buy
+398,426
New +$3.41M 0.01% 406

Other funds holding SCLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ken Fisher's SCLN Position: Q3 2017 in Review

Ken Fisher sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q3 2017, closing a stake of 226,335 shares — an estimated $2.49M sold.

Ken Fisher first reported a position in SCLN in Q3 2015 and held it in 8 quarters. The position peaked at $5.86M in Q1 2016. 129 funds tracked by Wall St. Rank hold SCLN as of Q3 2017.

  • Ken Fisher reported no remaining Sciclone Pharmaceuticals Inc position as of Q3 2017 after selling out during the quarter.
  • Ken Fisher sold 226,335 Sciclone Pharmaceuticals Inc shares in Q3 2017, an estimated $2.49M.
  • Ken Fisher first reported a position in Sciclone Pharmaceuticals Inc in Q3 2015 and held it in 8 quarters.
  • Ken Fisher's Sciclone Pharmaceuticals Inc position peaked at $5.86M in Q1 2016.
  • 129 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2017.

Based on Fisher Asset Management's 13F filing for Q3 2017, filed 17 Oct 2017.